BioMed Research International

Review Article

Pulmonary Rehabilitation for Exercise Tolerance and Quality of Life in IPF Patients: A Systematic Review and Meta-Analysis

Table 2

Results of sensitivity analysis.
OutcomesDeletionResult
6MWDDariusz et al. 2008χ2=4.44, P<0.0001, I2=10%MD47.48, 95% CI: 25.99 to 68.97
He et al. 2016χ2=4.01, P<0.00001, I2=0%MD51.77, 95% CI: 30.27 to 73.27
Jackson et al. 2014χ2=2.48, P<0.00001, I2=0%MD53.72, 95% CI: 32.91 to 74.52
Nishiyama et al. 2008χ2=4.48, P <0.0001, I2=11%MD49.41, 95% CI: 27.00 to 71.83
Vainshelboim et al. 2015χ2=4.50, P <0.00001, I2=11%MD48.67, 95% CI: 28.10 to 69.24
Vainshelboim et al. 2016χ2=1.66, P =0.0004, I2=0%MD39.85, 95% CI: 17.79 to 61.91
SGRQ scoresGaunaurdet al.2014χ2=0.82, P =0.0002, I2=0%MD-7.11, 95% CI: -10.79 to -3.43
Nishiyama et al. 2008χ2=3.26, P<0.0001, I2=39%MD-8.48, 95% CI: -12.60 to -4.37
Vainshelboim et al. 2015χ2=2.87, P=0.0001, I2=30%MD-9.17, 95% CI: -13.83 to -4.52
Vainshelboim et al. 2016χ2=3.20, P=0.0009, I2=38%MD-7.14, 95% CI: -11.36 to -2.93
FVC%He et al. 2016χ2=1.23, P=0.007, I2=19%MD4.00, 95 %CI: -0.32 to8.32
Vainshelboim et al. 2015χ2=0.48, P=0.003, I2=0%MD4.68, 95% CI: 0.55 to 8.81
Vainshelboim et al. 2016χ2=0.20, P=0.36, I2=0%MD2.15, 95% CI: -2.42 to 6.72
DLCO%He et al. 2016χ2=0.02, P=0.42, I2=0%MD1.72, 95% CI: -2.43 to 5.87
Vainshelboim et al. 2015χ2=0.98, P=0.10, I2=0%MD3.59, 95% CI: - 0.66 to7.84
Vainshelboim et al. 2016χ2=0.76, P=0.07, I2=0%MD3.74, 95% CI: -0.35 to7.84